European Commission approves cenobamate for the treatment of adults with epilepsy

It is approved for the adjunctive treatment of focal-onset seizures with or without secondary generalisation in adults who have not been adequately controlled despite a history of treatment with at least two anti-epileptic medicines. The MHRA is currently reviewing the submission

Source:

PharmaTimes